{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:07:10Z","timestamp":1792602430639,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC 111-2811-B-182A-014"],"award-info":[{"award-number":["NSTC 111-2811-B-182A-014"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 110-2314-B-182A-063-MY3"],"award-info":[{"award-number":["MOST 110-2314-B-182A-063-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41417-026-01005-y","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:33:40Z","timestamp":1770485620000},"page":"289-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ataxia-telangiectasia mutated kinase inhibition overcomes gemcitabine resistance in intrahepatic cholangiocarcinoma via DNA ligase I-dependent repair vulnerability"],"prefix":"10.1038","volume":"33","author":[{"given":"Sheng-Hsuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-2674","authenticated-orcid":false,"given":"Yi-Ru","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Hsien","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Kuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1455-092X","authenticated-orcid":false,"given":"Chun-Nan","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"1005_CR1","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"SI Ilyas","year":"2013","unstructured":"Ilyas SI, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145:1215\u201329.","journal-title":"Gastroenterology"},{"key":"1005_CR2","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273\u201381.","journal-title":"N Engl J Med"},{"key":"1005_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.gendis.2015.07.003","volume":"2","author":"Y Jia","year":"2015","unstructured":"Jia Y, Xie J. Promising molecular mechanisms responsible for gemcitabine resistance in cancer. Genes Dis. 2015;2:299\u2013306.","journal-title":"Genes Dis"},{"key":"1005_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nature10760","volume":"481","author":"CJ Lord","year":"2012","unstructured":"Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature. 2012;481:287\u201394.","journal-title":"Nature"},{"key":"1005_CR5","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","volume":"461","author":"SP Jackson","year":"2009","unstructured":"Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071\u20138.","journal-title":"Nature"},{"key":"1005_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrm3546","volume":"14","author":"Y Shiloh","year":"2013","unstructured":"Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol. 2013;14:197\u2013210.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1005_CR7","doi-asserted-by":"publisher","first-page":"eaat1719","DOI":"10.1126\/sciadv.aat1719","volume":"4","author":"ST Durant","year":"2018","unstructured":"Durant ST, Zheng L, Wang Y, Chen K, Zhang L, Zhang T, et al. The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv. 2018;4:eaat1719.","journal-title":"Sci Adv"},{"key":"1005_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","volume":"16","author":"PG Pilie","year":"2019","unstructured":"Pilie PG, Tang C, Mills GB, Yap TA. State-of-the-art strategies for targeting the DNA damage response in cancer. Nat Rev Clin Oncol. 2019;16:81\u2013104.","journal-title":"Nat Rev Clin Oncol"},{"key":"1005_CR9","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-04-2727","volume":"64","author":"I Hickson","year":"2004","unstructured":"Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 2004;64:9152\u20139.","journal-title":"Cancer Res"},{"key":"1005_CR10","doi-asserted-by":"crossref","unstructured":"Verma S, Grindrod N, Breadner D, Lock M. The current role of radiation in the management of cholangiocarcinoma-a narrative review. Cancers. 2024;16:1776.","DOI":"10.3390\/cancers16091776"},{"key":"1005_CR11","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1073\/pnas.1521597113","volume":"113","author":"G Lu","year":"2016","unstructured":"Lu G, Duan J, Shu S, Wang X, Gao L, Guo J, et al. Ligase I and ligase III mediate the DNA double-strand break ligation in alternative end-joining. Proc Natl Acad Sci USA. 2016;113:1256\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1005_CR12","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1073\/pnas.1521630113","volume":"113","author":"S Masani","year":"2016","unstructured":"Masani S, Han L, Meek K, Yu K. Redundant function of DNA ligase 1 and 3 in alternative end-joining during immunoglobulin class switch recombination. Proc Natl Acad Sci USA. 2016;113:1261\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1005_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41417-023-00705-z","volume":"31","author":"YR Pan","year":"2024","unstructured":"Pan YR, Lai JC, Huang WK, Peng PH, Jung SM, Lin SH, et al. PLK1 and its substrate MISP facilitate intrahepatic cholangiocarcinoma progression by promoting lymphatic invasion and impairing E-cadherin adherens junctions. Cancer Gene Ther. 2024;31:322\u201333.","journal-title":"Cancer Gene Ther"},{"key":"1005_CR14","doi-asserted-by":"crossref","unstructured":"Pan YR, Wu CE, Yeh CN. ATM inhibitor suppresses gemcitabine-resistant BTC growth in a polymerase theta deficiency-dependent manner. Biomolecules. 2020;10:1529.","DOI":"10.3390\/biom10111529"},{"key":"1005_CR15","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"EP Rogakou","year":"1998","unstructured":"Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998;273:5858\u201368.","journal-title":"J Biol Chem"},{"key":"1005_CR16","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.4161\/cc.9.14.12363","volume":"9","author":"EA Rahal","year":"2010","unstructured":"Rahal EA, Henricksen LA, Li Y, Williams RS, Tainer JA, Dixon K. ATM regulates Mre11-dependent DNA end-degradation and microhomology-mediated end joining. Cell Cycle. 2010;9:2866\u201377.","journal-title":"Cell Cycle"},{"key":"1005_CR17","doi-asserted-by":"publisher","first-page":"102496","DOI":"10.1016\/j.coph.2024.102496","volume":"80","author":"N Kumari","year":"2025","unstructured":"Kumari N, Kaur E, Raghavan SC, Sengupta S. Regulation of pathway choice in DNA repair after double-strand breaks. Curr Opin Pharmacol. 2025;80:102496.","journal-title":"Curr Opin Pharmacol"},{"key":"1005_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.radonc.2014.04.001","volume":"111","author":"M Toulany","year":"2014","unstructured":"Toulany M, Mihatsch J, Holler M, Chaachouay H, Rodemann HP. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition. Radiother Oncol. 2014;111:228\u201336.","journal-title":"Radiother Oncol"},{"key":"1005_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yexcr.2018.03.006","volume":"366","author":"K Li","year":"2018","unstructured":"Li K, Yan H, Guo W, Tang M, Zhao X, Tong A, et al. ATM inhibition induces synthetic lethality and enhances sensitivity of PTEN-deficient breast cancer cells to cisplatin. Exp Cell Res. 2018;366:24\u201333.","journal-title":"Exp Cell Res"},{"key":"1005_CR20","doi-asserted-by":"publisher","first-page":"114382","DOI":"10.1016\/j.yexcr.2024.114382","volume":"444","author":"D Ozdemir","year":"2025","unstructured":"Ozdemir D, Agca CA. AZD1390, an Ataxia telangiectasia mutated inhibitor, enhances cisplatin mediated apoptosis in breast cancer cells. Exp Cell Res. 2025;444:114382.","journal-title":"Exp Cell Res"},{"key":"1005_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrc3007","volume":"11","author":"AC Begg","year":"2011","unstructured":"Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 2011;11:239\u201353.","journal-title":"Nat Rev Cancer"},{"key":"1005_CR22","doi-asserted-by":"publisher","first-page":"102808","DOI":"10.1016\/j.ctrv.2024.102808","volume":"129","author":"JH Lee","year":"2024","unstructured":"Lee JH. Targeting the ATM pathway in cancer: opportunities, challenges and personalized therapeutic strategies. Cancer Treat Rev. 2024;129:102808.","journal-title":"Cancer Treat Rev"},{"key":"1005_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.18632\/aging.204487","volume":"15","author":"LY Chiu","year":"2023","unstructured":"Chiu LY, Sun Q, Zenke FT, Blaukat A, Vassilev LT. Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death. Aging. 2023;15:492\u2013512.","journal-title":"Aging"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01005-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:55:58Z","timestamp":1777013758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01005-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1005"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01005-y","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors confirm that all methods were performed in accordance with the relevant guidelines and regulations. The animal experiments of this study were approved by the Institutional Animal Care and Utilization Committee of Chang Gung Memorial Hospital (IACUC 2020112502).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}